Clinical Trials - Clinical Trials Arena

Palleon Pharmaceuticals reports Phase I/II trial results of E-602 for solid tumours

gullapalli — Mon, 11 Nov 2024 07:55:11 +0000

Palleon has reported the outcomes from its Phase I/II study of E-602 with PD-1 inhibitor cemiplimab to treat patients with solid tumours.

gullapalli — Fri, 08 Nov 2024 14:28:51 +0000

OncoResponse has unveiled the outcomes from the Phase I trial of OR502 for treating advanced solid tumours.

gullapalli — Fri, 08 Nov 2024 10:55:52 +0000

Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 study of QUTENZA to treat PSNP.

gullapalli — Fri, 08 Nov 2024 09:58:56 +0000

Radella Pharmaceuticals has reported topline outcomes from a Phase Ia trial that assessed an investigational therapy for obesity and diabetes.

gullapalli — Thu, 07 Nov 2024 15:50:26 +0000

Minghui Pharmaceutical has reported promising initial outcomes from its Phase I trial of MHB039A to treat patients with solid tumours.

gullapalli — Thu, 07 Nov 2024 10:59:43 +0000

Senhwa has enrolled the first subject for a Phase I/II trial of Silmitasertib in conjunction with chemotherapy to treat solid tumours.

gullapalli — Thu, 07 Nov 2024 09:15:56 +0000

Ionis has announced the design for a Phase III trial of ION582, a treatment for Angelman syndrome (AS), following discussions with the FDA.

gullapalli — Wed, 06 Nov 2024 13:56:55 +0000

Zymeworks has dosed the first patient in its Phase I clinical trial of ZW191 aimed at treating advanced solid tumours.

gullapalli — Wed, 06 Nov 2024 11:01:02 +0000

Ankyra Therapeutics has announced the dosing of the first patient with a visceral tumour in part two of its Phase I clinical trial of ANK-101.

gullapalli — Wed, 06 Nov 2024 09:52:11 +0000

Research Grid has raised a $6.5m seed funding round led by Fuel Ventures, to improve the success rate of clinical trials.